Ledger.Open graph →
SEC Form D · filed October 1, 2018

KSQ Therapeutics, Inc

Offering
$80.6M
Sold
$80.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

George L. Golumbeski · CAMBRIDGE, MADirectorAlan L. Crane · CAMBRIDGE, MADirectorDavid P. Meeker, M.D · CAMBRIDGE, MAExec · DirectorDavid A. Berry, M.D., Ph.D · CAMBRIDGE, MADirectorRichard A. Moscicki, Ph.D · CAMBRIDGE, MADirectorJames L. Gilbert · CAMBRIDGE, MADirectorJohn P. Trzupek, Ph.D · CAMBRIDGE, MAExecFrank P. Stegmeier, Ph.D · CAMBRIDGE, MAExecGeorge L. Golumbeski · CAMBRIDGE, MADirectorRichard A. Moscicki, Ph.D · CAMBRIDGE, MADirectorAlan L. Crane · Rochester, NYDirectorJames L. Gilbert · CAMBRIDGE, MADirectorJohn P. Trzupek, Ph.D · CAMBRIDGE, MAExecDavid P. Meeker, M.D · CAMBRIDGE, MAExec · DirectorFrank P. Stegmeier, Ph.D · CAMBRIDGE, MAExecDavid A. Berry, M.D., Ph.D · CAMBRIDGE, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗